pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    paliperidone ER
    Paliperidone
    Schizoaffective Disorder Eskayef Pharmaceuticals Ltd1 cat
  • palonosetron
    POSFREA (PALONOSETRON)
    no indication D Y Patil University School of Medicine1 cat
  • Marketed
    paltusotine hydrochloride
    Palsonify (paltusotine hydrochloride)
    Carcinoid Syndrome (Malignant Carcinoid Syndrome)$CRNX Crinetics Pharmaceuticals, Inc.1 cat
  • Marketed
← prev
page 31 of 271
next →
Pain89
Neurology1
pegzilarginase
Loargys (pegzilarginase-nbln)
Hyperargininemia (Arginase I Deficiency)
Immedica Pharma AB
1 cat
  • pertuzumab + trastuzumab
    no indication Xijing Hospital1 cat
  • Marketed
    pertuzumab biosimilar
    Poherdy (pertuzumab-dpzb)
    Human Epidermal Growth Factor Receptor 2 Positive Breast… EirGenix Inc1 cat
  • phenylephrine
    no indication Sawai Man Singh Medical College1 cat
  • Phase 2
    pirenzepine
    pirenzepine
    Diabetic Peripheral Neuropathy WinSanTor Inc1 cat
  • Marketed
    plozasiran sodium
    Redemplo (plozasiran sodium)
    Hypertriglyceridemia$ARWR ARROWHEAD PHARMACEUTICALS, INC.1 cat
  • pneumococcal (20-valent) vaccine
    no indication Beijing Minhai Biotechnology Co Ltd1 cat
  • polyphenol-rich cocoa extract
    no indication German Sport University Cologne1 cat
  • Marketed
    propranolol hydrochloride ER
    Propranolol Hydrochloride
    Angina (Angina Pectoris) Par Pharmaceutical Inc1 cat
  • Marketed
    pseudoephedrine hydrochloride ER
    Pseudoephedrine Hydrochloride
    Nasopharyngitis (Common Cold) Perrigo Pharmaceuticals Company (Inactive)1 cat
  • pucotenlimab
    no indication Lepu Biopharma Co Ltd1 cat
  • Marketed
    rabies vaccine
    RabAvert
    Rabies Bavarian Nordic AS1 cat
  • Phase 3
    raludotatug deruxtecan
    raludotatug deruxtecan
    Adenocarcinoma Of The Gastroesophageal Junction Daiichi Sankyo Co Ltd1 cat
  • recombinant type III humanized collagen
    no indication Chinese Academy of Medical Sciences Plastic Surgery Hospital1 cat
  • Marketed
    remibrutinib
    Rhapsido (remibrutinib)
    Chronic Inducible Urticaria$NVS NOVARTIS AG1 cat
  • Marketed
    riboflavin 5'-phosphate sodium
    Photrexa Viscous (riboflavin 5'-phosphate sodium)
    Keratoconus$GKOS GLAUKOS Corp1 cat
  • Marketed
    rilpivirine hydrochloride ODT
    Edurant PED (rilpivirine hydrochloride)
    Human Immunodeficiency Virus (HIV) Infections (AIDS)$JNJ JOHNSON & JOHNSON1 cat
  • risvutatug rezetecan
    no indication Changzhou Hengbang Pharmaceutical Co Ltd1 cat
  • Marketed
    rivastigmine ER
    Rivastigmine
    Dementia Mylan Technologies Inc1 cat
  • rosuvastatin
    ROSUVASTATIN
    no indication Mahatma Gandhi Medical College and Hospital1 cat
  • Marketed
    ruxolitinib
    Jakafi (ruxolitinib)
    myelofibrosis, polycythemia vera, graft-versus-host disease Sun Pharmaceutical Industries Ltd1 cat
  • pre_registration
    sacituzumab govitecan
    Trodelvy (sacituzumab govitecan)
    Triple-Negative Breast Cancer (TNBC)$GILD GILEAD SCIENCES, INC.1 cat
  • Phase 2
    samuraciclib
    samuraciclib [INN]
    Breast Cancer Carrick Therapeutics Ltd1 cat
  • Phase 3
    serplulimab
    serplulimab
    Small-Cell Lung Cancer Shanghai Henlius Biotech Inc1 cat
  • Marketed
    sevabertinib
    Hyrnuo (sevabertinib)
    Non-Small Cell Lung Cancer Bayer AG1 cat
  • shatavari
    no indication Ixoreal Biomed Pvt Ltd1 cat
  • Marketed
    sibeprenlimab
    Voyxact (sibeprenlimab-szsi)
    Sicca Syndrome (Sjogren) Visterra Inc1 cat